Improving observational studies in the era of big data

The Lancet

Volumn 392, Issue 10149, 2018, Pages 716-717

  Gill, Jennifer ^a,b   Prasad, Vinay ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIG DATA; BREAST CANCER; CANCER PATIENT; DIFFUSE LARGE B CELL LYMPHOMA; ELECTRONIC HEALTH RECORD; FOLLOW UP; HUMAN; NOTE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; FACTUAL DATABASE; MEDICAL RESEARCH;

BIOMEDICAL RESEARCH; DATABASES, FACTUAL;

EID: 85052535402     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(18)31619-2     Document Type: Note

References (7)

1. Senn, S, Seven myths of randomisation in clinical trials. Stat Med 32 (2013), 1439–1450.
2. El-Galaly, TC, Jakobsen, LH, Hutchings, M, et al. Routine imaging for diffuse large B-cell lymphoma in first complete remission does not improve post-treatment survival: a Danish–Swedish population-based study. J Clin Oncol 33 (2015), 3993–3998.
3. Hernán, MA, Alonso, A, Logan, R, et al. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology 19 (2008), 766–779.
4. Hernán, MA, Robins, JM, Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol 183 (2016), 758–764.
5. Giobbie-Hurder, A, Gelber, RD, Regan, MM, Challenges of guarantee-time bias. J Clin Oncol 31 (2013), 2963–2969.
6. Patel, CJ, Burford, B, Ioannidis, JPA, Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations. J Clin Epidemiol 68 (2015), 1046–1058.
7. Prasad, V, Jena, AB, Prespecified falsification end points: can they validate true observational associations?. JAMA 309 (2013), 241–242.